Sp1056
PRESENTATION OF ESOPHAGEAL, GASTRIC & DUODENAL DISORDERS (EGD) SECTION RESEARCH MENTOR AWARD: IKUO HIRANO, MD
Date
May 21, 2024
Presenters
Washington University School of Medicine
University of Colorado
Tracks
Related Products
MANOMETRIC SCREENING USING THE NOVEL MILAN SCORE IDENTIFIES LIKELIHOOD OF OBJECTIVE GASTROESOPHAGEAL REFLUX IN PATIENTS WITH LARYNGOPHARYNGEAL REFLUX SYMPTOMS
According to the Lyon 2.0 consensus, patients with laryngopharyngeal reflux (LPR) symptoms should undergo upfront pathophysiologic tests to evaluate for conclusive evidence of reflux prior to medical management…
EXTERNAL VALIDATION DEMONSTRATES HIGH PREDICTIVE VALUE OF THE LYON SCORE: A NOVEL REFLUX SCORING SYSTEM BASED ON THE LYON CONSENSUS 2.0
BACKGROUND: The Lyon Consensus 2.0 identifies physiologic, borderline and pathologic reflux burden from acid exposure time (AET), reflux episodes (RE), and mean nocturnal baseline impedance (MNBI)…
FLUTICASONE PROPIONATE ORAL DISINTEGRATING TABLET, APT-1011, LEADS TO A GREATER COMPLETE SYMPTOMATIC RESPONSE RATE COMPARED TO PLACEBO IN SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS (EOE)
The goals of treatment of eosinophilic esophagitis (EoE) are to improve clinical symptoms and histologic features, as well as prevent progression to fibrostenotic complications. Few data currently exist that evaluate the effectiveness of therapies as measured by complete resolution of symptoms…